David Hardy, M.D.
A diplomat of the American Board of Internal Medicine, Dr. Hardy is a member of numerous professional societies including the American Academy of HIV Medicine, for whom he serves as a member of the National Board of Directors and Chairman of the California/Hawaii Chapter. He works with several community organizations, and since 1988 he has been president of the Los Angeles Physicians AIDS Forum, which he co-founded. He has served on the scientific committees for various national and international HIV congresses. Dr. Hardy has been principal investigator on a number of HIV clinical trials.
Dr. Hardy has received grants or research support from Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Pfizer, and Tibotec. He has served as a consultant for Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Monogram, Pfizer, and Tibotec. He has received fees for non-CME services from Gilead Sciences, Pfizer, and Tibotec. He owns stock in Merck.